Back to Journals » Veterinary Medicine: Research and Reports » Volume 2

Rat model of nonalcoholic steatohepatitis created by methionine and choline deficiency: biochemical and histological analyses

Authors Nagai S, Iwamoto J, Suzuki M, Seki A

Published 18 July 2011 Volume 2011:2 Pages 1—8

DOI https://doi.org/10.2147/VMRR.S22205

Review by Single-blind

Peer reviewer comments 2

Shinichi Nagai1, Jun Iwamoto2, Masakazu Suzuki1, Azusa Seki1
1Hamri Co Ltd, Koga, Ibaraki, Japan; 2Institute for Integrated Sports Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
Background: The purpose of this study was to establish a Sprague-Dawley rat model of nonalcoholic steatohepatitis (NASH) due to combined methionine and choline deficiency (MCD).
Methods: Eighty nine-week-old male Sprague-Dawley rats were randomized into two groups (n = 40), comprising an MCD diet group and a standard diet (control) group. After fasting blood was collected, 10 rats from each group were scheduled to be sacrificed at weeks 4, 8, 12, and 16 from the start of the experiment. Body weight and liver wet weight were measured, and histological examination of the liver was performed after hematoxylin and eosin and Oil Red O staining.
Results: In the MCD group, body weight and liver wet weight were decreased compared with the control group, while serum levels of albumin, γ-glutamyltranspeptidase, alkaline phosphatase, and total bilirubin were increased, but serum levels of total cholesterol and triglycerides were decreased. Histological examination of the liver revealed centrilobular hepatocellular fatty change from as early as four weeks, with mild fibrosis after 12 weeks.
Conclusion: These findings suggested the onset of NASH with liver dysfunction and bile duct damage in rats fed with the MCD diet. Increased fatty acid uptake and decreased cholesterol secretion were considered to be important mechanisms by which the MCD diet promoted intrahepatic lipid accumulation in this model.

Keywords: nonalcoholic steatohepatitis, rat, methionine, choline, fatty liver
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis

Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al

Therapeutics and Clinical Risk Management 2010, 6:201-206

Published Date: 20 April 2010

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature

Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda, Hideo Matsumoto

Clinical Interventions in Aging 2008, 3:483-489

Published Date: 12 September 2008

Readers of this article also read:

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Topical diclofenac in the treatment of osteoarthritis of the knee

Niklas Schuelert, Fiona A Russell, Jason J McDougall

Orthopedic Research and Reviews 2011, 3:1-8

Published Date: 6 February 2011

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010